Consistently, a previous study showed that in breast cancer cell lines cMYC-binding protein MYCBP, a positive regulator of cMYC, is directly targeted by miR-22, leading to the downregulation of several E-box-containing cMYC target genes41. The gene discussed is MYC; the disease is breast cancer.